Stock Information
Royalty Pharma PLC (RPRX)
Ticker Symbol: RPRX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $26,674.17 mil
Piotroski score: 5
PE Ratio: 34.6991
EPS (TTM): 1.3652
Revenue (TTM): $4.27 M
Dividend Yield: 2.0280474649407%
ROE: 11.89%
Latest News
-
Royalty Pharma Announces R&D Co-Funding Agreement With Johnson & Johnson For Total Of $500M In 2026 And 2027 To Advance Development Of JNJ-4804, Investigational Medicine For Autoimmune Diseases
Mon, Mar 30, 2026 7:24 AM
-
Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment
Fri, Mar 27, 2026 1:51 PM
Key Financials
Financial data not available
